2026 NPPES data Oncology Pharmacist NPI 1124777800 PHARMD
Verify on CMS →

HANNAH BUSTILLOS, PHARMD

Oncology Pharmacist in SEATTLE, Washington. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
13
Medicare Part D claims · Oncology Pharmacist avg: 160
What the federal data reveals: HANNAH BUSTILLOS, PHARMD is a Oncology Pharmacist ([object Object]) practicing in SEATTLE, Washington with a Medicare Part D prescribing footprint of 13 claims .

What stands out: HANNAH BUSTILLOS, PHARMD filed 13 Medicare Part D claims in 2023 across SEATTLE, Washington. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

HANNAH BUSTILLOS, PHARMD at a glance

Quality data not reported

NPI registry status

Active

Issued 03/21/2022

NPI 1124777800

Primary specialty

Oncology Pharmacist

Niche

1,699 US NPIs in this specialty

Medicare Part D claims

13 92% vs specialty avg

2023 prescription claims

Specialty avg: 160

Specialty distribution in Washington

How Oncology Pharmacist compares to other specialties among Washington providers

Washington providers

Oncology Pharmacist share within Washington

1. Oncology Pharmacist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Oncology Pharmacist share within Washington

Specialty board-certification context

Estimated specialty board-certified rate — Oncology Pharmacist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Oncology Pharmacist ABMS/AOA estimate

Est. board-certified rate (Oncology Pharmacist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Oncology Pharmacist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

HANNAH BUSTILLOS, PHARMD is a Oncology Pharmacist provider practicing in SEATTLE, Washington, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: PHARMD. NPI: 1124777800. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

HANNAH BUSTILLOS, PHARMD appears in the CMS NPPES registry as a Oncology Pharmacist provider holding PHARMD credentials at 1354 ALOHA ST, SEATTLE, WA, 98109, with a listed phone of (206) 606-6279. NPI 1124777800 was issued on 03/21/2022. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BUSTILLOS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 13 prescription claims written by this provider, covering N/A Medicare beneficiaries and totaling roughly $233K in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Oncology Pharmacist is a narrow specialty nationwide, with 1,699 enrolled providers across 50 states and an average of 160 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1354 ALOHA ST
SEATTLE, WA 98109

Provider Details

NPI 1124777800
Specialty Oncology Pharmacist
Credentials PHARMD
Gender Female
NPI Issued 03/21/2022

License & disciplinary context — Washington WMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~34K Washington medical licensees in 2023 — they are NOT specific to HANNAH BUSTILLOS, PHARMD. To verify HANNAH BUSTILLOS, PHARMD's current license status, search the WMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

88
Total board actions, Washington 2023
Across 85 cases
2.59
Actions per 1,000 licensees
Washington statewide rate
probation
Most common action type
31 cases

WMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Washington disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

13
Total Claims
$233K
Total Drug Cost
N/A
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
13
Total Day Supply
364

Patient Demographics

Average Patient Age
69.0 years
Avg HCC Risk Score
2.84

Oncology Pharmacist Overview

How HANNAH BUSTILLOS, PHARMD fits within the Oncology Pharmacist landscape nationally.

1,699
Oncology Pharmacist Providers in US
50
States with Oncology Pharmacist
160
Avg Claims per Provider

HANNAH BUSTILLOS, PHARMD's 13 claims are below the specialty average of 160.

Nearby Oncology Pharmacist Providers in Washington

Other clinicians with the same primary specialty enrolled in Washington, drawn from the same CMS NPPES roster as BUSTILLOS.

Compare Oncology Pharmacist nationally: see state-by-state distribution →

Frequently Asked Questions

What is HANNAH BUSTILLOS, PHARMD's specialty?
HANNAH BUSTILLOS, PHARMD specializes in Oncology Pharmacist and practices in SEATTLE, Washington. Credentials: PHARMD.
How much does HANNAH BUSTILLOS, PHARMD prescribe under Medicare Part D?
In 2023, HANNAH BUSTILLOS, PHARMD wrote 13 Medicare Part D claims totaling $233K in drug costs for N/A beneficiaries.
Where is HANNAH BUSTILLOS, PHARMD located?
HANNAH BUSTILLOS, PHARMD is located at 1354 ALOHA ST, SEATTLE, WA, 98109. Phone: (206) 606-6279.
What is HANNAH BUSTILLOS, PHARMD's NPI number?
HANNAH BUSTILLOS, PHARMD's National Provider Identifier (NPI) is 1124777800, issued on 03/21/2022.
How many Oncology Pharmacist providers are there in the US?
There are 1,699 Oncology Pharmacist providers across 50 states in the US. The average Oncology Pharmacist provider writes 160 Medicare Part D claims per year.
Does HANNAH BUSTILLOS, PHARMD accept Medicare?
HANNAH BUSTILLOS, PHARMD appears in CMS Medicare data with 13 Part D claims and N/A Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify HANNAH BUSTILLOS, PHARMD's credentials?
HANNAH BUSTILLOS, PHARMD's NPI is 1124777800 with credentials PHARMD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology